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Summary
Background: Pubertal insulin resistance (IR) is associated with increased risk of type
2 diabetes mellitus development in adolescents with overweight/obesity.
Objectives: The PREVIEW study was a randomized parallel trial assessing the change
in IR, analyzed by Homeostatic Model Assessment of IR (HOMA-IR), at 2 years after
randomization to a high protein vs a moderate protein diet in adolescents with over-
weight/obesity. It was hypothesized that a high protein/low glycaemic index diet
would be superior in reducing IR compared to a medium protein/medium GI diet, in
insulin resistant adolescents with overweight or obesity.
Methods: Adolescents with overweight/obesity and IR from the Netherlands, United
Kingdom and Spain were randomized into a moderate protein/moderate GI (15/55/
30En% protein/carbohydrate/fat, GI ≥ 56) or high protein/low GI (25/45/30En% pro-
tein/carbohydrate/fat, GI < 50) diet. Anthropometric and cardiometabolic parame-
ters, puberty, dietary intake and physical activity (PA) were measured and effects on
HOMA-IR were analyzed.
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Results: 126 adolescents were included in this study (13.6 ± 2.2 years, BMI z-score
3.04 ± 0.66, HOMA-IR 3.48 ± 2.28, HP n = 68, MP n = 58). At 2 years, changes in
protein intake were not significantly different between timepoints or intervention
groups and no effects of the intervention on IR were observed. The retention rate
was 39%, while no compliance to the diets was observed.
Conclusions: The PREVIEW study observed no effect of a high protein/low GI diet
on IR in adolescents with overweight/obesity and IR because of lack of feasibility,
due to insufficient retention and dietary compliance after 2 years.
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1 | INTRODUCTION
The prevalence of childhood obesity has rapidly increased over the
last decades and, without adequate management, is expected to rise
to approximately 268 million children globally in 2025 with a subse-
quent increase in obesity-related comorbidities.1-3 During puberty,
transient insulin resistance (IR) is a common physiological phenome-
non.4-9 IR is defined as reduced ability of insulin to increase glucose
uptake and utilization, resulting in a compensatory increase in insulin
secretion to maintain normal blood glucose concentrations.7 A tran-
sient increase in IR during puberty is considered to be a physiological
phenomenon of growth, but especially adolescents with obesity show
an exaggerated increase in IR. In addition, in adolescents with obesity,
IR does not appear to decrease at the end of puberty as is observed in
lean adolescents.5,6,9 Particularly adolescents with obesity therefore
may have increased risk for β-cell exhaustion and development of
T2DM even at a young age.5 Furthermore, it has been shown that
both obesity and IR are associated with development of cardiovascu-
lar disease, for example, dyslipidaemia and hypertension even in child-
hood.8,10 Moreover, adolescents with IR were less successful in
decreasing BMI z-score in response to interventions than adolescents
that are not insulin resistant.4,11 Thus, particularly in adolescents with
overweight or obesity and increased IR, interventions should focus on
decreasing BMI z-score and assess whether the increase of Homeo-
static Model Assessment of IR (HOMA-IR) during pubertal IR can be
attenuated.
Recommendations of the US Preventive Services Task Force
and others include comprehensive, multidisciplinary lifestyle inter-
ventions for treatment of obesity in children, although there is no
consensus on the most efficient and effective type of dietary and
physical activity (PA) strategy.11,12 Earlier observations report that
a relative increase of dietary protein, thereby reducing fat and
carbohydrate intake, led to a significant reduction in obesity.11-18
Two studies showed that a higher-protein diet reduced IR signifi-
cantly.12,17 One study that combined increased protein intake
with decreased glycaemic index (GI) observed a significant reduc-
tion in percentage of children with overweight/obesity in this
group compared to control diets.17 Proposed underlying
mechanisms for these effects might be the ability of protein to
increase satiety, thermogenesis and fat-oxidation, thus reducing
fat mass while maintaining fat free mass during energy restric-
tion.19 Lowering GI in diets has been suggested to promote sati-
ety and reduces hunger, although few long-term studies have
been performed in adolescents to confirm these effects.20 In addi-
tion, PA alone and in combination with a dietary intervention, has
been shown to change body composition by increasing fat free
mass, and reducing fat mass, fasting glucose concentrations and
IR.21-23 Especially lifestyle interventions combining diet, PA, and
behavioural strategies have been effective in decreasing obesity
and reducing IR and cardiovascular risk parameters in youths.22
However, studies researching the effects of combined lifestyle
intervention in adolescents with overweight/obesity and
increased IR are scarce. Thus far, three large community studies
have been performed aiming to decrease IR parameters in adoles-
cents with overweight/obesity, of which two showed significant
favourable changes in glucose metabolism abnormalities and BMI z-
score after short-term, intensive intervention.24-26 However, life-
style interventions in adolescents in free-living conditions often
report problems with participants meeting dietary targets and
maintaining PA levels.26,27 Specifically, previous studies aiming to
increase relative protein intake reported difficulties in dietary compli-
ance and participants meeting protein targets, and were mostly con-
ducted under controlled settings (eg, meal observation in in-centre
settings).11,13-18 Therefore, the effect of a lifestyle intervention of a
high protein/low GI diet in adolescents with overweight/obesity and
increased IR, should be addressed in real-life settings.
The PREVention of diabetes through lifestyle Intervention and
population studies in Europe and around the World (PREVIEW) study
in adolescents was a randomized clinical study assessing the change in
IR, analyzed as HOMA-IR, at 2 years after randomization to a high
protein/low GI vs a moderate protein/moderate GI diet, in adoles-
cents with overweight/obesity. It was hypothesized that a high pro-
tein/low GI diet would be superior in reducing IR compared to a
medium protein/medium GI diet, in insulin resistant adolescents with
overweight or obesity. In addition, in both diet groups PA was encour-
aged and monitored.
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2 | MATERIALS AND METHODS
2.1 | Study design
The PREVIEW study in adolescents was a multicentre, 104-week
parallel-group, gender-stratified block-randomized (10:10) trial between
December 2013 and December 2018, as described previously.28 The
first 8 weeks aimed at weight stabilization during growth. All participants
received sample menus based on their estimated energy requirements,
consisting of 15/55/30 energy percent (En%) protein/carbohydrate/
fat.29 In the second phase, adolescents were randomized into a moderate
protein/moderate GI (MP) or a high protein/low GI (HP) group. Randomi-
zation was stratified by sex, age and centre in blocks of 10 using a com-
puterized randomization tool. The MP group received a sample menu
with a macronutrient composition of 15/55/30 En% protein/carbohy-
drate/fat and a GI≥56. The HP group received a sample menu with a tar-
get macronutrient composition of 25/45/30 En% protein/carbohydrate/
fat and a GI ≤ 50. All menus were tailored to the participant's estimated
energy requirements. Upon request, further personalized tips were given
taking for example, cultural traditions into account. In addition, in the
perspective of pre-diabetes related health, participants were instructed
to increase PA (in organized sports and daily movement). Due to the per-
sonalized instructions for participants during the measurement meetings,
participants and research staff could not be blinded. The study was
designed as a 2 years randomized clinical trial. The study protocol was
approved by local Medical Ethics Committees at all study sites. The study
was compliant with the Declaration of Helsinki and ICH-GCP.
2.2 | Participants
Adolescents were recruited from three study sites (Maastricht Univer-
sity, the Netherlands; University of Navarra, Spain and Swansea Uni-
versity, UK) between December 2013 and December 2016 by ED, NS
and SNC. Inclusion criteria were overweight/obesity (BMI z-score
>1.0 SDS), increased IR (defined as HOMA-IR >2.0 for adolescents
Tanner G/M stages ≥3 or any HOMA-IR for adolescents at Tanner
stages 1-2) and signed informed consent from both parents and ado-
lescents ≥12 years.28 Exclusion criteria included medical conditions or
use of medication that might influence study outcomes (eg, T2DM,
bariatric surgery and use of metformin) or compromise study adher-
ence (eg, severe food intolerances or musculoskeletal diseases).
2.3 | Measurements
2.3.1 | Anthropometric characteristics and body
composition
Height and weight were measured at baseline, after 1 and 2 years while
participants were barefoot, wearing only underwear and in a fasted
state, and subsequently BMI was calculated. Because BMI in adoles-
cents is not a representative measure of obesity status due to periods
of growth, age- and gender-adjusted BMI z-scores were calculated
(TNO Growth Calculator, TNO, Den Haag, the Netherlands).30 Body
composition was measured with air-displacement plethysmography (at
Maastricht University: BodPod, Life Measurement Instruments, Con-
cord, California) using the Lohman algorithm, bio-impedance measure-
ments (at University of Navarra: BIA, Tanita SC-330. Tanita Corp,
Tokyo, Japan), or dual energy x-ray absorptiometry (at Swansea Univer-
sity: DEXA, Stratos dR, Medimaging UK).31 Pubertal stage was deter-
mined with the Tanner genital (boys) or mammary (girls) scale.32,33
2.3.2 | Glucose metabolism
Blood samples were obtained by venepuncture after an overnight
fast by trained healthcare professionals. All samples were centrifuged
and frozen locally, and subsequently analysed at the laboratory for
clinical chemistry at Maastricht University. Concentrations of fasting
blood glucose were analysed with the COBAS 800 modular analyser
(Roche, Woerden, the Netherlands). Fasting insulin and HbA1c con-
centrations were determined using the fully automated HPLC Variant
II 155 (Bio-Rad Laboratories, Veenendaal, the Netherlands) and
C-peptide concentrations with the Immulite XPI (Siemens, Eindhoven,
the Netherlands). An index for IR was calculated using HOMA-IR
(fasting glucose concentration (mmol/L) × fasting insulin concentra-
tion (mU/L)/22.5).34
2.3.3 | Compliance: Food intake and PA
Compliance to the dietary instructions was assessed using four-day
food records, provided at each measurement visit, and which were
subsequently analysed for energy intake, macronutrient composition
including protein content (both g/d as En%), fibre content, GI and
glycaemic load (GL) using the Eetmeter food diary and analysis tool
(Voedingscentrum, Den Haag, the Netherlands). Compliance to the
diet was further assessed by the Three Factor Eating Questionnaire
(TFEQ), consisting of the three factors cognitive restraint of eating,
disinhibition and hunger, where increase in cognitive restraint, and
decreases in disinhibition and hunger are indicators for successful
dieting in general.35-38 To assess underreporting, reported total
energy intake was compared to the daily energy requirements for chil-
dren and adolescents using the WHO formula to assess
underreporting [total energy expenditure (MJ/day) = 1.298 +
0.265 kg–0.0011 kg2 (boys) or 1.102 + 0.273 kg–0.0019 kg2 (girls)].29
PA was assessed with 7-day accelerometry (Actigraph GT3X acceler-
ometer, Actigraph Corp.) and the Baecke Questionnaire.39 Participants
were instructed to wear the accelerometer on the right hip during
seven full days and nights, only removing the accelerometer during
showering, swimming or contact sports. Wear time validation was
performed with a minimum of 4 days >10 hours including 1 weekend-
day. Epochs were measured with the length of 10 seconds and
Evenson cut-off points were used to assess moderate, light and vigor-
ous activity.40,41
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2.4 | Statistical analyses
Power calculations were performed using G*power (Dusseldorf Uni-
versity, Dusseldorf, Germany) and adjusted for an estimated 25%
drop-out. With an α of .05, effect size of .37 for HOMA-IR and sam-
ple size of 100, a power of 0.96 could be achieved.28 To remain suf-
ficient power for analyses at 2 years despite drop-out, intention-to-
treat analyses were performed on the complete dataset after multi-
ple imputation. For this, 50 datasets were created (MICE Package in
R, v3.2.3, Vienna, Austria). The maximum number of iterations was
set to 20, where convergence was checked by inspecting the trace
lines. The following predictors were used to impute missing values:
gender, age, Tanner stage and BMI z-score at baseline and at 1 or
2 years, and the baseline value of the imputed variable. Estimated
effect changes over time in the intention-to-treat analyses were
pooled from the multiple imputed datasets, analysed using factorial
ANOVA's with repeated measures and presented as mean (95% con-
fidence interval). As this was an exploratory study, no corrections
for multiple comparisons have been made. All statistical analyses
were performed using IBM SPSS Statistics for Windows version 24
(IBM Corp., Armonk, New York). A P-value <.05 was considered to
be statistically relevant.
3 | RESULTS
3.1 | Characteristics of the participants
In total, 126 adolescents were included in the baseline analyses
between December 2013 and December 2016, as described previ-
ously.26 After 1 years of intervention 83 participants (66% retention
rate) were still participating, and after 2 years, 49 participants (39%
F IGURE 1 Study flowchart
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retention rate) completed the study (Figure 1). Reasons for drop-out
were discontinuation of the study due to personal reasons (n = 4)
and loss to follow-up (n = 77). Baseline characteristics of adoles-
cents who dropped out were not significantly different from adoles-
cents that remained in the study. No serious adverse events were
reported.
Baseline descriptives of the HP and MP group are presented in
Tables 1 and 2. No significant differences between the groups were
observed in gender, BMI z-score, HOMA-IR or other glucose metabo-
lism or lifestyle parameters.
3.2 | Compliance to dietary instructions
Absolute and relative reported protein intake, as a percentage of total
energy intake, were not significantly changed after 1 and 2 years of
TABLE 1 Estimated effect changes in food intake and PA parameters after 1 and 2 years of intervention
Baseline
Estimated effect changes after 1 y
(after multiple imputation)
Estimated effect changes after 2 y
(after multiple imputation)
HP (n = 68) MP (n = 58) HP (n = 68) MP (n = 58) HP (n = 68) MP (n = 58)
Outcome Mean ± SD Mean ± SD Δ (95% CI) Δ (95% CI) Δ (95% CI) Δ (95% CI)
Food intake
GI 50.9 ± 7.7 54.3 ± 8.7 0.0 (−4.6, 4.6) −2.7 (−7.9, 2.6) −1.4 (−3.5, 0.6) −2.8 (−5.4, −0.2)*
GL 93.4 ± 30.9 103.0 ± 32.8 −8.2 (−24.7, 8.2) −20.3 (−41.8, 1.1) −6.8 (−17.2, 3.7) −14.5 (−30.1, 1.0)
Energy intake (MJ/d) 6.7 ± 1.6 7.3 ± 2.3 −0.9 (−1.7, −0.1)* −1.2 (−2.1, −0.3)* 0.0 (−0.5, 0.5) −0.6 (−1.6, 0.1)
Protein (g/d) 70.0 ± 19.2 70.9 ± 17.4 −6.0 (−13.7, −1.8) −4.4 (−11.7, 2.8) −1.7 (−6.5, 3.0) −4.3 (−10.9, 2.2)
Protein (En%) 17.5 ± 2.4 16.9 ± 3.7 1.8 (−1.1, 4.7) 1.8 (−0.7, 4.4) −0.5 (−2.2, 1.2) 0.3 (−1.7, 2.2)
Fat (g/d) 65.9 ± 23.5 70.2 ± 29.3 −9.4 (−20.3, 1.5) −12.4 (−25.0, 0.1) 2.3 (−3.4, 8.1) −2.9 (−11.2, 5.3)
Fat (En%) 35.9 ± 7.8 35.4 ± 6.9 0.8 (−6.6, 8.2) 0.8 (−6.2, 7.8) 1.4 (−2.5, 5.2) 1.2 (−3.4, 5.9)
Carbohydrate (g/d) 176.3 ± 46.0 200.9 ± 74.2 −25.2 (−48.8, −1.6) −34.0 (−68.3, 0.4) −4.0 (−21.1, 13.2) −18.4 (−41.3, 4.5)
Carbohydrate (En%) 44.7 ± 7.8 45.6 ± 6.1 0.9 (−7.0, 8.9) 0.8 (−6.7, 8.3) −0.8 (−5.7, 4.1) 0.0 (−5.9, 6.0)




10.6 ± 3.6 11.5 ± 4.1 1.2 (−0.6, 3.0) 0.6 (−1.5, 2.6) 2.4 (0.6, 4.1)** 1.8 (−0.3, 3.9)
TFEQ disinhibition 6.7 ± 3.5 5.4 ± 3.0 −0.1 (−1.5, 1.3) 0.6 (−0.9, 2.0) 0.7 (−1.4, 2.7) 2.7 (0.3, 5.1)*
TFEQ hunger 5.8 ± 3.7 4.9 ± 2.5 −1.0 (−3.1, 1.0 0.1 (−1.5, 1.8) 0.8 (−1.5, 3.1) 2.3 (−0.4, 5.0)
PA parameters
Baecke school 2.4 ± 0.3 2.6 ± 0.4 0.1 (0.0, 0.2) −0.1 (−0.2, 0.1) −0.0 (−0.2, 0.1) −0.2 (−0.4, −0.0)*
Baecke sport 2.7 ± 0.5 2.8 ± 0.5 0.1 (−0.1, 0.3) 0.1 (−0.1, 0.3) −0.1 (−0.3, 0.1) −0.2 (−0.4, 0.1)
Baecke leisure 2.9 ± 0.6 2.8 ± 0.7 0.0 (−0.2, 0.2) 0.0 (−0.2, 0.3) −0.1 (−0.3, 0.2) −0.0 (−0.3, 0.2)
Baecke total score 8.0 ± 1.0 8.2 ± 1.1 0.2 (−0.2, 0.5) 0.1 (−0.3, 0.4) −0.1 (−0.5, 0.2) −0.4 (−0.8, −0.0)
Accelerometer counts
(kcpd)
309.4 ± 99.9 279.4 ± 103.1 27.7 (−10.5, 65.9) 39.5 (−0.3, 79.4) 4.2 (−46.4, 54.8) 60.9 (5.7, 116.0)*
Accelerometery counts
(cpm)
316.6 ± 101.9 291.0 ± 118.7 104.2 (60.2, 148.3)** 109.2 (58.3, 160.1)** 51.7 (1.1, 102.3)* 107.1 (48.2, 166.0)**
Sedentary behaviour
(min/d)








Light PA (min/d) 335.0 ± 7.8 306.7 ± 69.1 −40.6 (69.9, −11.3)** −29.6 (−59.9, 0.8) −37.1 (−71.8, −2.4)* 3.4 (−37.9, 44.6)
Moderate PA (min/d) 22.2 ± 13.3 20.3 ± 16.9 6.7 (2.3, 11.1)** 8.0 (2.8, 13.1)** 3.0 (−2.7, 8.7) 7.4 (0.8, 14.)*
Vigorous PA (min/d) 4.7 ± 4.8 4.7 ± 5.4 5.7 (2.3, 9.1)** 4.8 (1.5, 8.2)** 2.8 (0.0, 5.6)* 3.8 (0.8, 6.9)*
Moderate-to-vigorous
PA (min/d)
26.9 ± 16.4 25.1 ± 19.2 12.3 (6.4, 18.2)** 12.6 (5.9, 19.4)** 5.7 (3.7, 12.1) 11.4 (4.0, 18.8)**
Note: Estimated effect changes are based upon imputated datasets. P-values are based upon comparison with baseline values. *P<.05; **P<.01.
Abbreviations: BMI, body mass index; cpd, counts per day; cpm, counts per minute; En%, percentage of total energy intake; FFM, fat free mass; FM, fat
mass; GI, glycaemic index; GL, glycaemic load; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance [glucose (mmol/L)/insulin (mU/
L) × 22,5—34]; HP, high protein/low glycaemic index; MP, medium protein/medium glycaemic Index; PA, physical activity; TFEQ, Three Factor Eating
Questionnaire.35
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intervention in the HP and MP group (Table 1). No significant differ-
ences were observed between the two intervention groups regarding
dietary intake, despite TFEQ scores indicating an increase in cognitive
dietary restraint over time.
3.3 | Effects of the dietary intervention on IR,
metabolic and anthropometric parameters
No significant differences were observed between the two interven-
tion groups regarding IR, parameters of glucose metabolism, anthro-
pometric characteristics or lifestyle factors at any timepoint
(Table 2).
4 | DISCUSSION
This PREVIEW study aimed to assess the effects of a high protein/
low GI vs a medium protein/medium GI diet on IR in adolescents
with overweight and obesity and IR. No significant differences were
found in reported protein intake and GI between the two
intervention groups, despite groups receiving different dietary
instructions. No significant differences were observed between the
two intervention groups regarding IR, parameters of glucose metab-
olism, anthropometric characteristics or lifestyle factors at any
timepoint. We conclude that the study was not feasible.
Lack of feasibility was due to poor retention rates and lack of die-
tary compliance. Retention rates were 66% after 1 year and 39% after
2 years. The HP group did not achieve the protein target of 25En%
and reported protein intake was not significantly different between
the two intervention groups. One possible explanation might be that
the protein intake estimates were based upon self-reported food dia-
ries, which are known to be underreported.42 Reported energy intake
was 32.6% to 62.1% lower than the energy requirements according to
the WHO formula for adolescents of corresponding ages and
weights.29 The unmet protein target might partly be explained by
reduced reward mechanisms in the brain or costs of high-protein
foods.43 Previous studies aiming to increase relative protein intake in
adolescents also reported difficulties in dietary compliance.11,13-18
Only half of them observed a difference in protein En% between the
higher-protein and the control group, which was often lower than the
targets set between 22.5 and 25.0 En%.14,16,18 None of the studies
TABLE 2 Estimated effect changes in anthropometric characteristics, body composition and parameters of glucose metabolism after 1 and
2 years of intervention
Baseline
Estimated effect changes after 1 y
(after multiple imputation)
Estimated effect changes after 2 y
(after multiple imputation)
HP (n = 68) MP (n = 58) HP (n = 68) MP (n = 58) HP (n = 68) MP (n = 58)
Outcome Mean ± SD Mean ± SD Δ (95% CI) Δ (95% CI) Δ (95% CI) Δ (95% CI)
General characteristics
Girls n (%) 39 (57.4%) 35 (60.3%)
Age (y) 13.7 ± 2.4 13.4 ± 2.0 1.1 (1.1, 1.2)** 1.1 (1.1, 1.2)** 2.2 (2.0, 2.3)** 2.2 (2.0, 2.3)**
Tanner stage 3 (2–5) 3 (2–4) 0.6 (0.3, 0.8)** 0.5 (0.3, 0.8)** 0.8 (0.4, 1.2)** 0.7 (0.3, 1.1)**
Anthropometric characteristics
Height (m) 1.61 ± 0.11 1.60 ± 0.10 0.05 (0.04, 0.06)** 0.05 (0.04, 0.07)** 0.08 (0.05, 0.11)** 0.09 (0.06, 0.11)**
Weight (kg) 80.0 ± 20.9 75.7 ± 18.2 8.3 (1.1, 15.5)* 10.6 (3.6, 17.6)** 4.4 (−1.5, 10.4) 3.0 (−2.9, 8.9)
BMI (kg/m2) 30.1 ± 5.1 29.3 ± 4.6 1.3 (−1.1, 3.6) 2.3 (−0.3, 4.9) −0.33 (−1.8, 1.2) −0.5 (−1.8, 0.8)
BMI z-score (SD) 3.10 ± 0.69 2.97 ± 0.63 −0.22 (−0.33, −0.10)** −0.09 (−0.21, 0.03) −0.16 (−0.36, 0.04) −0.22 (−0.46, 0.01)
Fat free mass (kg) 47.5 ± 12.3 46.2 ± 10.5 3.0 (1.5, 4.5)** 3.6 (2.0, 5.3)** 6.8 (3.7, 9.9)** 6.0 (3.3, 8.7)**
Fat mass (kg) 32.4 ± 12.3 29.3 ± 11.0 1.0 (−0.9, 3.0) 2.7 (0.7, 4.7)** 5.0 (1.4, 8.6)** 4.0 (−0.3, 8.4)
Fat mass (%) 40.0 ± 7.4 38.2 ± 8.9 −1.1 (−4.7, 2.5) −0.5 (−3.8, 2.9) 1.4 (−0.9, 3.7) 2.0 (−0.8, 4.8)
Parameters of glucose metabolism
Glucose (mmol/L) 4.6 ± 0.7 4.5 ± 0.7 0.2 (−0.1, 0.4) 0.2 (−0.0, 0.5) 0.3 (0.1, 0.6)* 0.4 (0.1, 0.7)**
Insulin (pmol/L) 107.2 ± 51.5 112.4 ± 94.6 −5.8 (−25.6, 13.8) 2.5 (−22.6, 27.6) 28.1 (−11.4, 67.6) 13.2 (−25.5, 51.9)
HOMA-IR 3.44 ± 1.66 3.24 ± 1.96 0.19 (−0.55, 0.94) 0.45 (−0.47, 1.37) 0.85 (−0.00, 1.72) 0.89 (−0.00, 1.78)
HbA1c (mmol/mol) 32.7 ± 2.9 32.8 ± 2.5 0.1 (−0.8, 1.0) 0.5 (−0.4, 1.5) 0.7 (−0.3, 1.7) 0.9 (−0.2, 2.0)
C-peptide (nmol/L) 0.9 ± 0.3 0.9 ± 0.3 0.0 (−0.1, 0.1) 0.0 (−0.1, 0.1) 0.1 (−0.0, 0.2) 0.0 (−0.1, 0.2)
Note: Estimated effect changes are based upon imputated datasets. P-values are based upon comparison with baseline values. *P<.05; **P<.01.
Abbreviations: BMI, body mass index; cpd, counts per day; cpm, counts per minute; En%, percentage of total energy intake; FFM, fat free mass; FM, fat
mass; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance [glucose (mmol/L)/insulin (mU/L) × 22,5—34]; HP, high protein/low glycaemic index;
MP, medium protein/medium glycaemic index; PA, physical activity; TFEQ, Three Factor Eating Questionnaire.35
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observed a difference in BMI z-score decrease between intervention
groups. The results from this study imply that achieving and
maintaining a high protein/low GI diet during 2 years is not feasible
with instructions alone. Achieving and maintaining an energy target of
25 En% protein might only be feasible with vouchers/subsidies for
foods high in protein, the use of protein supplements or meal replace-
ments. Although an increase in cognitive dietary restraint over time
was observed, indicating general attention for dieting, this appeared
to be insufficient to contribute to compliance to the specific diets.
Furthermore, HOMA-IR stabilized after 1 and 2 years of lifestyle
intervention, despite progression in pubertal stage. As described pre-
viously, transient pubertal IR typically nadirs at mid-puberty,
suggesting that the PREVIEW lifestyle intervention prevented further
IR increase.5,6 Half of the previously performed studies where
reported protein intake did increase significantly observed a reduction
in HOMA-IR in adolescents with an increased-protein diet.11,12,14
However, these studies did not take pubertal stage into account.
By including all adolescents at increased risk of T2DM, regardless
of age or specific obesity status, the study design was placed in a real
life setting. Limitations were the use of HOMA-IR as a proxy of IR,
and absence of an untreated control group due to ethical consider-
ations of performing research in adolescents. In addition, no qualita-
tive data were required on why participants did not meet the protein
target and costs of diets was not considered in this study.
In conclusion, the PREVIEW study observed no effect of a high
protein/low GI diet on IR in adolescents with overweight/obesity and
IR because of lack of feasibility due to insufficient retention and die-
tary compliance.
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